Roundtable Report: Importance of Antiretroviral Drug Concentrations in Sanctuary Sites and Viral Reservoirs (Q73255202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Roundtable report: importance of antiretroviral drug concentrations in sanctuary sites and viral reservoirs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Roundtable Report: Importance of Antiretroviral Drug Concentrations in Sanctuary Sites and Viral Reservoirs (English)

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

23 December 2023

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

23 December 2023

2

Angela Kashuba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689408

23 December 2023

author name string

John Gerber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Veronica Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Rondtable Participants, Forum for Collaborative HIV Research

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y. Sunila Reddy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689408

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689408

23 December 2023

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

http://www.liebertpub.com/doi/pdf/10.1089/088922203763315669

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

AIDS Research and Human Retroviruses

23 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

167-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

The challenge of viral reservoirs in HIV-1 infection

2 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Sexual transmission of HIV.

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Epidemiological parameters of HIV transmission

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

23 December 2023

5

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Intracellular and cell-free (infectious) HIV-1 in rectal mucosa

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men.

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Effect of antiviral treatment on the shedding of HIV-1 in semen

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

23 December 2023

27

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission

23 December 2023

28

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Transmission of zidovudine-resistant HIV-1 through heterosexual contacts

23 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

HIV-1 drug resistance in newly infected individuals

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

23 December 2023

33

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

23 December 2023

42

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Human immunodeficiency virus and the brain

23 December 2023

43

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid

23 December 2023

45

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

HIV in the brain: RNA levels and patterns of zidovudine resistance

23 December 2023

46

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

23 December 2023

47

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

23 December 2023

48

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Comparison of imipenem and ceftazidime as therapy for severe melioidosis

23 December 2023

50

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group

23 December 2023

51

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

23 December 2023

52

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir.

23 December 2023

53

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations

23 December 2023

54

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection

23 December 2023

55

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Drug Metabolism and Disposition

23 December 2023

56

28

1058

Washington CB

2000

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

23 December 2023

57

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

23 December 2023

58

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

23 December 2023

59

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

23 December 2023

60

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.

23 December 2023

61

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir

23 December 2023

62

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

23 December 2023

67

1 reference

https://api.crossref.org/works/10.1089/088922203763315669

23 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689408%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference